Obalon Therapeutics, Inc. Gains 139.71%

Tue 14 Apr 20 at 05:30 PM
Obalon Therapeutics, Inc. Gains 139.71%

Obalon Therapeutics, Inc. (OBLN:NASDAQ) rocketted at $1.63, a gain of 139.7%. The stock appeared on our News Catalysts scanner on Wed 25 Mar 20 at 06:33 PM in the 'MISCELLANEOUS' category. From Mon 30 Mar 20, the stock recorded 33.33% Up Days and 30.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Obalon Therapeutics, Inc. (OBLN:NASDAQ)

Obalon Therapeutics Inc is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.